No article in the knowledge graph for Olink yet.
Who is Olink?
Olink is a life sciences tools company that provides proteomics platforms and assay technologies for measuring protein biomarkers in research and translational settings.
- Multiplex protein biomarker assay panels
- Proximity-based immunoassay technology
- Research-use proteomics instruments and analysis software
- Translational and clinical research support
- Biomarker discovery workflows for pharmaceutical and academic customers
More About
Olink positions its offerings within the life sciences research market, where laboratories need to quantify large numbers of proteins from small sample volumes. Its assay platforms are typically used in pharmaceutical development, academic research, and translational studies that seek to link protein expression patterns to disease states, treatment response, or safety signals. Researchers commonly deploy these workflows to screen cohorts, validate candidate biomarkers, and generate data for downstream statistical and machine learning analysis.
Show more
The technical foundation of the company's approach centers on proximity-based immunoassay methods. In these methods, paired antibody probes bind to a target protein, and when the probes are in close proximity, a DNA reporter sequence is formed and amplified for quantification. This design supports multiplexed measurement, allowing many analytes to be profiled in parallel within a single sample. Data outputs are generally processed through laboratory information management and bioinformatics pipelines, which makes integration with existing research data infrastructure an important consideration for enterprise and institutional buyers.
In comparison with other solution categories, proteomics platforms differ in throughput, sensitivity, dynamic range, and the degree of sample preparation required. Mass spectrometry based proteomics offers broad discovery coverage, while targeted immunoassay platforms generally provide higher throughput and more standardized quantification for defined protein panels. Organizations selecting between these approaches typically weigh study design, sample volume, and reproducibility requirements.
The business significance of these offerings lies in their role within drug discovery and biomarker research pipelines, where protein-level data can inform target selection, patient stratification, and clinical trial design. For technical leaders, the relevant considerations include instrument operations, data governance, validation documentation, and compatibility with analytical environments. Within a technology directory, the company is positioned in the life sciences tools segment, focused on protein analysis solutions that support research workflows and related data management needs.
Our description of Olink. Updated October 2026.
